Numis disclosed Vectura Group PLC (LON:VEC), hiking its stock price target to 252.00GBX earlier today
- Updated: September 18, 2016
Only yesterday Vectura Group PLC (LON:VEC) traded 1.86% higher at 145.35GBX. Vectura Group PLC’s 50-day average is 140.58GBX and its two hundred day moving average is 156.71GBX. With the last stock price down 7.51% from the two hundred day moving average, compared to the Standard & Poor’s 500 Index which has decreased -0.01% over the date range. 656,670 shares of Vectura Group PLC traded, down from ann avg. trading volume of 1,992,380.
Numis upped the price target of Vectura Group PLC (LON:VEC) to 252GBX, stating a possible upside of 0.73%,
Previously on 9/07/2016, Peel Hunt reported about Vectura Group PLC(LON:VEC) kept the target price at 200.00GBX. At the time, this suggested an upside of 0.00%.
Recent Performance Graph:
Also covering Vectura Group PLC’s price target, a total of 6 analysts have released a ratings update on Vectura Group PLC. The consensus target stock price is 215.67GBX with four analysts rating the stock a strong buy, two analysts rating the company a buy, one analyst rating the stock a hold, 0 rating the company to underperform, and lastly 0 analysts rating the stock as sell.
Vectura Group PLC has a price-earnings of 121 with a 52 week low of 122.90GBX and a one-year high of 200.10GBX and has a market cap of 0.0 GBX.
About Vectura Group PLC (LON:VEC)
Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, and Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.